Cancer Immunotherapy Market
According to Intent Market Research, the Cancer Immunotherapy Market is expected to grow from USD 154.5 billion in 2023 at a CAGR of 11.9% to touch USD 338.3 billion by 2030. The Cancer Immunotherapy Market is dominated by key players such as Bristol Myers Squibb, Merck & Co., Inc., Roche Holding AG, Johnson & Johnson, Novartis International AG, Pfizer, Inc., Eli Lilly and Co., AstraZeneca PLC, Sanofi S.A., Amgen Inc., Regeneron Pharmaceuticals, Inc., Gilead Sciences, Inc., AbbVie Inc., Celgene Corporation, GlaxoSmithKline PLC.